Sanara MedTech (NASDAQ:SMTI) reported quarterly sales of $9.70 million which beat the analyst consensus estimate of $7.81 million by 24.20 percent. This is a 54.53 percent increase over sales of $6.28 million the same period last year.
Financial Times Reported Thursday Vodafone Plans Hundreds Of Job Cuts In Bid To Rein In Costs
https://www.ft.com/content/ae366c72-a7e6-4ccb-942d-8e5323b4ea5e